Historique de carrière de Andrew King
Anciens postes connus de Andrew King
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 07/06/2021 | 09/08/2023 |
| Corporate Officer/Principal | 01/05/2019 | 07/06/2021 | |
| ARDELYX, INC. | Corporate Officer/Principal | - | - |
Formation de Andrew King
| Murdoch University | Undergraduate Degree |
| Michigan State University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Australie | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARDELYX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- Andrew King
- Expérience
